BLOOM:PSEBloomberry Resorts Corporation Analysis
Data as of 2026-06-01 - not real-time
$285.00
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Bloom Energy is riding a strong bullish price trend, with the short‑term moving average comfortably above the medium‑term average and price trading well above recent support levels. Momentum indicators show a moderate RSI in the mid‑fifties and a bearish MACD histogram, suggesting short‑term pressure despite the broader uptrend. Fundamentally, the company posted explosive revenue growth of over 130% in the latest quarter and has raised its full‑year guidance, positioning it as a key player in the data‑center power niche. However, valuation metrics are extreme: forward price‑to‑earnings is many times the industry average and the discounted cash‑flow fair value is a fraction of the current market price, implying that the market has priced in very optimistic growth assumptions. The balance sheet shows ample cash but also a debt load that translates to a very high leverage ratio, while profit margins remain thin. Combined with a volatility profile approaching 100% over the past month and a beta nearly four times the market, the stock is highly sensitive to market sentiment, which is currently at an “Extreme Greed” level.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram indicating near‑term downside pressure
- Extremely high valuation relative to DCF fair value
- Strong support level providing limited downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustained revenue acceleration and raised guidance
- Strategic positioning in AI‑driven data‑center power demand
- Improving operating cash flow despite thin profit margins
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Long‑term growth tailwinds from clean‑energy transition and hydrogen adoption
- Potential for margin expansion as technology scales
- Robust cash position to fund future investments and R&D
Key Metrics & Analysis
Financial Health
Revenue Growth130.40%
Profit Margin0.25%
P/E Ratio65.5
ROE1.29%
ROA3.09%
Debt/Equity311.48
P/B Ratio87.9
Op. Cash Flow$298.2M
Free Cash Flow$265.5M
Industry P/E29.9
Technical Analysis
TrendBullish
RSI56.2
Support$241.75
Resistance$322.83
MA 20$284.86
MA 50$223.67
MA 200$138.21
MACDBearish
VolumeStable
Fear & Greed Index93.13
Valuation
Fair Value$32.20
Target Price$263.13
Upside/Downside-7.67%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta3.94
Volatility99.30%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.